Device Trial Radar · NCT04210609
Effectiveness of Vaporous Hyperoxia Therapy (VHT) in the Treatment of Chronic Diabetic Foot Ulcers
Last checked: Nov 20, 2026Latest source record: Oct 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
30
Planned (sponsor's estimate)
Start
Oct 4, 2021
Primary completion
Oct 3, 2022
Study completion Oct 3, 2022
Sponsor
- Lead sponsor
- VaporoxNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 24, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effectiveness of Vaporous Hyperoxia Therapy (VHT) for the treatment of Diabetic Foot Ulcers.
Conditions
- Diabetic Foot Ulcer
Interventions
Vaporous Hyperoxia TherapyDevice
55 minutes of treatment, 2 times per week
Primary outcomes
What the sponsor says the trial is designed to measure.
- Wound closure rate at 20 weeksTime frame: 20 weeks
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Rock Canyon Foot and Ankle Clinic
Castle Rock, Colorado
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.